Responses of equine tendon-and bone marrow-derived cells to monolayer expansion with fibroblast growth factor-2 and sequential culture with pulverized tendon and insulinlike growth factor-I

American Journal of Veterinary Research

Volumn 73, Issue 1, 2012, Pages 162-170

  Durgam, Sushmitha S ^a   Stewart, Allison A ^a   Pondenis, Holly C ^a   Yates, Angela C ^a,c   Evans, Richard B ^b   Stewart, Matthew C ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Biostatistical Retriever   (United States)

^c Franklin Animal Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL EXPANSION; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; COLLAGEN METABOLISM; CONTROLLED STUDY; GLYCOSAMINOGLYCAN METABOLISM; IN VITRO STUDY; IN VIVO STUDY; MONOLAYER CULTURE; NONHUMAN; STEM CELL; SUPPLEMENTATION; TENDINITIS; TENDON;

ANIMALS; BLOTTING, NORTHERN; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; COLLAGEN TYPE I; COLLAGEN TYPE III; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; HORSES; INSULIN-LIKE GROWTH FACTOR I; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TENDONS;

EQUIDAE;

EID: 84855253995     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.1.162     Document Type: Article

References (45)

1. Ely ER, Avella CS, Price JS, et al. Descriptive epidemiology of fracture, tendon and suspensory ligament injuries in National Hunt racehorses in training. Equine Vet J 2009;41:372-378.
2. Lam KH, Parkin TD, Riggs CM, et al. Descriptive analysis of retirement of Thoroughbred racehorses due to tendon injuries at the Hong Kong Jockey Club (1992-2004). Equine Vet J 2007;39:143-148.
3. Avella CS, Ely ER, Verheyen KLP, et al. Ultrasonographic assessment of the superficial digital flexor tendons of National Hunt racehorses in training over two racing seasons. Equine Vet J 2009;41:449-454.
4. Kasashima Y, Takahashi T, Smith RF, et al. Prevalence of superficial digital flexor tendonitis and suspensory desmitis in Japanese Thoroughbred flat racehorses in 1999. Equine Vet J 2004;36:346-350.
5. Dowling BA, Dart AJ, Hodgson DR, et al. Superficial digital flexor tendonitis in the horse. Equine Vet J 2000;32:369-378.
6. Chesen AB, Dabareiner RM, Chaffin MK, et al. Tendinitis of the proximal aspect of the superficial digital flexor tendon in horses: 12 cases (2000-2006). J Am Vet Med Assoc 2009;234:1432-1436.
7. Kaneps AJ. Surgical options for treating tendon and ligament injuries. Clin Tech Equine Pract 2007;6:209-216.
8. Bosch G, de Mos M, van Binsbergen RV, et al. The effect of focused extracorporeal shock wave therapy on collagen matrix and gene expression in normal tendons and ligaments. Equine Vet J 2009;41:335-341.
9. Patterson-Kane JC, Firth EC. The pathobiology of exerciseinduced superficial digital flexor tendon injury in Thoroughbred racehorses. Vet J 2009;181:79-89.
10. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000). Equine Vet J 2004;36:415-419.
11. Richardson LE, Dudhia J, Clegg PD, et al. Stem cells in veterinary medicine-attempts at regenerating equine tendon after injury. Trends Biotechnol 2007;25:409-416.
12. Smith RK. Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil 2008;30:1752-1758.
13. Lacitignola L, Crovace A, Rossi G, et al. Cell therapy for tendinitis, experimental and clinical report. Vet Res Commun 2008;32(suppl 1):S33-S38.
14. Schnabel LV, Lynch ME, van der Meulen MC, et al. Mesenchymal stem cells and insulin-like growth factor-I gene enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res 2009;27:1392-1398.
15. Ju YJ, Muneta T, Yoshimura H, et al. Synovial mesenchymal stem cells accelerate early remodeling of tendon-bone healing. Cell Tissue Res 2008;332:469-478.
16. Liu W, Chen B, Deng D, et al. Repair of tendon defect with dermal fibroblast engineered tendon in a porcine model. Tissue Eng 2006;12:775-788.
17. Cao Y, Liu Y, Liu W, et al. Bridging tendon defects using autologous tenocyte engineered tendon in a hen model. Plast Reconstr Surg 2002;110:1280-1289.
18. Nixon AJ, Dahlgren LA, Haupt JL, et al. Effect of adiposederived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 2008;69:928-937.
19. Bi Y, Ehrirchiou D, Kilts TM, et al. Identification of tendon stem/ progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007;13:1219-1227.
20. de Mos M, Koevoet WJLM, Jahr H, et al. Intrinsic differentiation potential of adolescent human tendon tissue: an in vitro cell differentiation study. BMC Musculoskelet Disord 2007;8:1-12.
21. Scutt N, Rolf CG, Scutt A. Tissue specific characteristics of cells isolated from human and rat tendons and ligaments. J Orthop Surg Res 2008;3:32-37.
22. Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364:149-155.
23. Stewart AA, Barrett JG, Byron CR, et al. Comparison of equine tendon-, muscle-, and bone marrow-derived cells cultured on tendon matrix. Am J Vet Res 2009;70:750-757.
24. Chintala SK, Miller RR, McDevitt CA. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes. Arch Biochem Biophys 1994;310:180-186.
25. Solchaga LA, Penick K, Porter JD, et al. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 2005;203:398-409.
26. Stewart AA, Byron CR, Pondenis H, et al. Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. Am J Vet Res 2007;68:941-945.
27. Chan BP, Fu S, Qin L, et al. Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: a rat patellar tendon model. Acta Orthop Scand 2000;71:513-518.
28. Chan BP, Chan KM, Maffulli N, et al. Effect of basic fibroblast growth factor. An in vitro study of tendon healing. Clin Orthop Relat Res 1997;342:239-247.
29. Duffy FJ, Seiler JG, Gelberman RH, et al. Growth factors and canine flexor tendon healing: initial studies in uninjured and repair models. J Hand Surg Am 1995;20A:645-649.
30. Chang J, Most D, Thunder R, et al. Molecular studies in flexor tendon wound healing: the role of basic fibroblast growth factor gene expression. J Hand Surg Am 1998;23A:1052-1058.
31. Dahlgren LA, van der Meulen MC, Bertram JE, et al. Insulin-like growth factor improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendonitis. J Orthop Res 2002;20:910-919.
32. Dahlgren LA, Mohammed HO, Nixon AJ. Temporal expression of growth factors and matrix molecules in healing tendon lesions. J Orthop Res 2005;23:84-92.
33. Dahlgren LA, Mohammed HO, Nixon AJ. Expression of insulinlike growth factor binding proteins in healing tendon lesions. J Orthop Res 2006;24:183-192.
34. Abrahamsson SO, Lohmander S. Differential effects of insulinlike growth factor-I on matrix and DNA synthesis in various regions and types of rabbit tendons. J Orthop Res 1996;4:370-376.
35. Costa MA, Wu C, Pham BV, et al. Tissue engineering of flexor tendons: optimization of tenocyte proliferation using growth factor supplementation. Tissue Eng 2006;12:1937-1943.
36. Strober W. Trypan blue exclusion test for cell viability. Curr Protoc Immunol 2001;5:Appendix 3B.
37. Gharaibeh B, Lu A, Tebbets J, et al. Isolation of a slowly adheringcell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc 2008;3:1501-1509.
38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001;25:402-408.
39. Diegelmann RF. Analysis of collagen synthesis. Methods Mol Med 2003;78:349-358.
40. Masuda K, Shirota H, Thonar EJ. Quantification of 35S-labeled proteoglycans complexed to alcian blue by rapid filtration in multiwell plates. Anal Biochem 1994;217:167-175.
41. Funakoshi T, Spector M. Chondrogenic differentiation and lubricin expression of caprine infraspinatus tendon cells. J Orthop Res 2010;28:716-725.
42. Tsutsumi S, Shimazu A, Miyazaki K, et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001;288:413-419.
43. Murphy DJ, Nixon AJ. Biochemical and site-specific effects of insulin-like growth factor I on intrinsic tenocytes activity in equine flexor tendons. Am J Vet Res 1997;58:103-109.
44. Dahlgren LA, Nixon AJ, Brower-Toland BD. Effects of β-aminopropionitrile on equine tendon metabolism in vitro and on effects of insulin-like growth factor-I on matrix production by equine tenocytes. Am J Vet Res 2001;62:1557-1562.
45. Hosaka YZ, Takahashi H, Uratsuji T, et al. Comparative study of the characteristics and properties of tendinocytes derived from three tendons in the equine forelimb. Tissue Cell 2010;42:9-17.